 | |
- close
- close
|
PR Newswire
Feb 2
Comment
WILMINGTON, Mass., Feb. 2 PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(®) (Nasdaq: DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan(®) Photodynamic Therapy (PDT) technology platform
StreetInsider.com
Dec 18
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/DUSA+Pharmaceuticals++%28DUSA%29+Up+On+Reports+of+FDA+Approval/5196461.html for the full story.
StreetInsider.com
Nov 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/DUSA+Pharma+%28DUSA%29+Encouraged+By+SCC+Study+to+Explore+Benefits+of+Levulan+PDT/5092166.html for the full story.
StreetInsider.com
Nov 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/DUSA+Pharma+%28DUSA%29+Posts+Q3+Loss+of+2c%2C+Beats+by+2c/5082641.html for the full story.
MarketWatch
Aug 10
Comment
Among the stocks expected to see active trading on Tuesday are Celadon Group Inc., Clearwire Corp., Fossil Inc. and North American Palladium Ltd.
New York Times
May 23
Comment
The Sufi scholars are part of a broad, moderate Islamist movement that Western nations are counting on to repel Somalia’s increasingly powerful Islamist extremists.
Marketwire
May 12
Comment
WILMINGTON, MA -- (Marketwire) -- 05/12/09 -- DUSA Pharmaceuticals, Inc.® (NASDAQ: DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and other products targeting patients with common skin conditions,
Marketwire
May 11
Comment
WILMINGTON, MA -- (Marketwire) -- 05/11/09 -- DUSA Pharmaceuticals, Inc.® (NASDAQ: DUSA) announced today the initiation of a DUSA-sponsored study that will examine the safety and efficacy of multiple broad area photodynamic therapy (PDT) for the
Marketwire
May 6
Comment
WILMINGTON, MA -- (Marketwire) -- 05/06/09 -- DUSA Pharmaceuticals, Inc.® (NASDAQ: DUSA) announces that its corporate highlights and first quarter financial results press release will be issued on Tuesday, May 12 at 6:30 a.m. to be followed by a
Marketwire
May 5
Comment
WILMINGTON, MA -- (Marketwire) -- 05/05/09 -- DUSA Pharmaceuticals, Inc.® (NASDAQ: DUSA) is pleased to announce that they are a supporting sponsor of The Skin Cancer Foundation's 2009 Road to Healthy Skin Tour. The tour, which officially hits the
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| ||||||
